---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-22-002576"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2022-02-28T23:59:59+00:00"
generated_at: "2026-06-27T03:58:31.278620+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health appoints Sandford as CEO, Palmieri as Executive Chair

## Summary
- Nicole Sandford appointed President and CEO effective March 1, 2022; base salary $500,000, one-year term.
- Valerie Palmieri transitions to Executive Chair effective March 1; base salary $450,000, one-year term.
- Celeste Fralick, Ph.D., appointed to Board effective Feb 23, 2022; will serve on Audit Committee.
- Bylaws amended to require lead director selection if Board chair is not an independent director.

## SEC filing metadata
- accession: 0001387131-22-002576
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2022-02-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/0001387131-22-002576-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/awh-8k_022322.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-22-002576
- JSON: https://secwatch.observer/filing/0001387131-22-002576.json
- Plain text: https://secwatch.observer/filing/0001387131-22-002576.txt

## Key facts
- Executive change
  Valerie B. Palmieri was appointed as Executive Chairperson at Aspira Women's Health Inc..
  - Action: appointed
  - Role: Executive Chairperson
  source text: On February 23, 2022, the board of directors (the “Board”) of Aspira Women’s Health Inc. (the “Company”) appointed Valerie B. Palmieri as its Executive Chairperson, effective as of March 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/0001387131-22-002576-index.htm
- Executive change
  Nicole Sandford was appointed as President and Chief Executive Officer at Aspira Women's Health Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On February 23, 2022, the Board appointed Nicole Sandford, a current director on the Board, as the Company’s President and Chief Executive Officer, effective as of March 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/0001387131-22-002576-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.